Sign in to follow
Search Results

0 results for 'Sanofi SA'

You can use to get even better search results
June 21, 2004 |

Arnold & Porter

2 minute read
June 13, 2007 |

Bristol-Myers Pleads Guilty in Plavix Antitrust Probe, to Pay $1 Million Fine

Bristol-Myers Squibb said it pleaded guilty to two counts of making false statements to the FTC and will pay a fine of $1 million. The company acknowledged that an unnamed "former senior executive" led Apotex to believe that Bristol-Myers would not launch a competing generic version of blood thinner Plavix if Apotex agreed to a settlement, and implied that then-chief executive Pete Dolan shared his views. In September, Bristol-Myers pushed out Dolan and said GC Richard K. Willard would leave the company.
2 minute read
June 01, 2010 |

The Professional

Serial whistle-blower Joseph Piacentile makes millions helping the government uncover fraud. That's how the False Claims Act is supposed to work. Or is it?
18 minute read
December 19, 2006 |

Federal Advisers Recommend Restricting Use of Controversial Antibiotic

Federal health advisers say the benefits of the antibiotic Ketek, which has been linked to reports of liver problems and several deaths, outweigh its risks in treating pneumonia, but not less severe infections like bronchitis and sinusitis. The advisers' review raises the possibility that the FDA will disapprove the drug for treatment of the lesser infections. A Senate committee is investigating the FDA's handling of Ketek, and one senator has accused the agency of withholding information on the drug.
3 minute read
March 21, 2011 |

Big Deals

8 minute read
May 03, 2004 |

N.J. Mergers & Acquisitions

Mergers and acquisitions involving N.J. companies
2 minute read
October 14, 2010 |

Applications for jobless benefits rise to 462K

More people applied for unemployment benefits last week, the first rise in three weeks and evidence that companies are reluctant to hire in a slow economy.
3 minute read
October 26, 2010 |

Bristol-Myers Squibb sees 3Q profit dip 2 percent

Bristol-Myers Squibb Co. posted a slight decline in third-quarter profit Tuesday as its restrained spending was offset by flat sales of its drugs, lower income from its partners and bigger discounts to government because of the health care overhaul.
4 minute read
June 21, 2004 |

Buyers Find Hope in Vitamin Case

The justices declared that foreign plaintiffs cannot sue in U.S. courts for antitrust violations outside the United States-but left open one line of argument that could make potential plaintiffs happy.
2 minute read
November 15, 2006 |

FDA Gives Antibiotic New Scrutiny After Reports of Fatalities

The antibiotic Ketek, linked to reports of severe liver problems, including several deaths, will be subjected to new scrutiny by U.S. health advisers, according to a federal notice. Meanwhile, the Senate Finance Committee is investigating allegations of fraud connected with trials of Ketek, or telithromycin, as well as how the FDA has handled relevant safety issues. Through April, the FDA received at least a dozen reports of acute liver failure, including four deaths, among patients treated with Ketek.
2 minute read

TRENDING STORIES

    More from ALM

    More from ALM

    Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

    Resources

    • Corporate Transparency Act Resource Kit

      Brought to you by Wolters Kluwer

      Download Now

    • Revenue, Profit, Cash: Managing Law Firms for Success

      Brought to you by Juris Ledger

      Download Now

    • Law Firm Operational Considerations for the Corporate Transparency Act

      Brought to you by Wolters Kluwer

      Download Now

    • The Ultimate Guide to Remote Legal Work

      Brought to you by Filevine

      Download Now